MA51132A - Sel de fumarate de l'urée (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phényl)-2,2,2-trifluoroéthyl)-1-méthyl-1-(1-méthylpipéridin-4-yl), procédés de préparation et utilisations de celui-ci - Google Patents
Sel de fumarate de l'urée (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phényl)-2,2,2-trifluoroéthyl)-1-méthyl-1-(1-méthylpipéridin-4-yl), procédés de préparation et utilisations de celui-ciInfo
- Publication number
- MA51132A MA51132A MA051132A MA51132A MA51132A MA 51132 A MA51132 A MA 51132A MA 051132 A MA051132 A MA 051132A MA 51132 A MA51132 A MA 51132A MA 51132 A MA51132 A MA 51132A
- Authority
- MA
- Morocco
- Prior art keywords
- methylpiperidin
- pyrazin
- trifluoroethyl
- dichloro
- phenyl
- Prior art date
Links
- -1 1- (2,3-DICHLORO-4- (PYRAZIN-2-YL) PHENYL) -2,2,2-TRIFLUOROETHYL Chemical class 0.000 title 2
- KKUGLUXXIGKECX-TYYBGVCCSA-N (e)-but-2-enedioic acid;urea Chemical compound NC(N)=O.OC(=O)\C=C\C(O)=O KKUGLUXXIGKECX-TYYBGVCCSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762597236P | 2017-12-11 | 2017-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA51132A true MA51132A (fr) | 2020-10-21 |
Family
ID=64901108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051132A MA51132A (fr) | 2017-12-11 | 2018-12-07 | Sel de fumarate de l'urée (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phényl)-2,2,2-trifluoroéthyl)-1-méthyl-1-(1-méthylpipéridin-4-yl), procédés de préparation et utilisations de celui-ci |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11299472B2 (fr) |
| EP (1) | EP3724176B1 (fr) |
| JP (1) | JP7171728B2 (fr) |
| KR (1) | KR20200097762A (fr) |
| CN (1) | CN111683934B (fr) |
| AU (1) | AU2018385438B2 (fr) |
| BR (1) | BR112020010803A2 (fr) |
| CA (1) | CA3083509A1 (fr) |
| CL (1) | CL2020001553A1 (fr) |
| DK (1) | DK3724176T3 (fr) |
| EA (1) | EA202091402A1 (fr) |
| ES (1) | ES2910030T3 (fr) |
| HU (1) | HUE058247T2 (fr) |
| IL (1) | IL275153B1 (fr) |
| LT (1) | LT3724176T (fr) |
| MA (1) | MA51132A (fr) |
| MX (1) | MX2020006026A (fr) |
| SI (1) | SI3724176T1 (fr) |
| WO (1) | WO2019118298A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL274072B1 (en) | 2017-12-11 | 2024-07-01 | Univ Muenchen Tech | PSMA ligands for imaging and endoradiotherapy |
| CN111303192A (zh) * | 2020-03-26 | 2020-06-19 | 西安瑞联新材料股份有限公司 | 一种3-氯-2-萘硼酸的工业化生产方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005048916A2 (fr) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Nouvelles carbolines-beta en tant qu'antagonistes de recepteur de secretagogue d'hormone de croissance |
| WO2011060397A1 (fr) | 2009-11-16 | 2011-05-19 | Schering Corporation | Amino heterocycles substitues utilises comme antagonistes du vih |
| WO2012113103A1 (fr) | 2011-02-25 | 2012-08-30 | Helsinn Healthcare S.A. | Urées asymétriques et leurs utilisations médicales |
| TWI690512B (zh) | 2014-03-07 | 2020-04-11 | 瑞士商赫爾辛保健股份有限公司 | 對位取代的不對稱脲及其醫療用途 |
-
2018
- 2018-12-07 LT LTEPPCT/US2018/064512T patent/LT3724176T/lt unknown
- 2018-12-07 DK DK18826892.4T patent/DK3724176T3/da active
- 2018-12-07 BR BR112020010803-0A patent/BR112020010803A2/pt unknown
- 2018-12-07 EP EP18826892.4A patent/EP3724176B1/fr active Active
- 2018-12-07 US US16/767,842 patent/US11299472B2/en active Active
- 2018-12-07 IL IL275153A patent/IL275153B1/en unknown
- 2018-12-07 AU AU2018385438A patent/AU2018385438B2/en active Active
- 2018-12-07 ES ES18826892T patent/ES2910030T3/es active Active
- 2018-12-07 MX MX2020006026A patent/MX2020006026A/es unknown
- 2018-12-07 WO PCT/US2018/064512 patent/WO2019118298A1/fr unknown
- 2018-12-07 SI SI201830563T patent/SI3724176T1/sl unknown
- 2018-12-07 MA MA051132A patent/MA51132A/fr unknown
- 2018-12-07 CA CA3083509A patent/CA3083509A1/fr active Pending
- 2018-12-07 EA EA202091402A patent/EA202091402A1/ru unknown
- 2018-12-07 KR KR1020207019718A patent/KR20200097762A/ko not_active Application Discontinuation
- 2018-12-07 JP JP2020531693A patent/JP7171728B2/ja active Active
- 2018-12-07 CN CN201880088431.4A patent/CN111683934B/zh active Active
- 2018-12-07 HU HUE18826892A patent/HUE058247T2/hu unknown
-
2020
- 2020-06-10 CL CL2020001553A patent/CL2020001553A1/es unknown
-
2022
- 2022-03-07 US US17/688,016 patent/US11884646B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN111683934B (zh) | 2024-01-23 |
| EP3724176A1 (fr) | 2020-10-21 |
| WO2019118298A1 (fr) | 2019-06-20 |
| IL275153B1 (en) | 2024-08-01 |
| JP7171728B2 (ja) | 2022-11-15 |
| CA3083509A1 (fr) | 2019-06-20 |
| HUE058247T2 (hu) | 2022-07-28 |
| MX2020006026A (es) | 2020-08-17 |
| US20200299260A1 (en) | 2020-09-24 |
| CL2020001553A1 (es) | 2020-11-06 |
| BR112020010803A2 (pt) | 2020-11-10 |
| EP3724176B1 (fr) | 2022-01-26 |
| EA202091402A1 (ru) | 2020-09-01 |
| CN111683934A (zh) | 2020-09-18 |
| ES2910030T3 (es) | 2022-05-11 |
| AU2018385438B2 (en) | 2022-12-15 |
| LT3724176T (lt) | 2022-04-25 |
| SI3724176T1 (sl) | 2022-04-29 |
| US11884646B2 (en) | 2024-01-30 |
| AU2018385438A1 (en) | 2020-05-28 |
| DK3724176T3 (da) | 2022-04-04 |
| JP2021505633A (ja) | 2021-02-18 |
| AU2018385438A8 (en) | 2020-06-04 |
| US20220340541A1 (en) | 2022-10-27 |
| US11299472B2 (en) | 2022-04-12 |
| IL275153A (en) | 2020-07-30 |
| KR20200097762A (ko) | 2020-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA52781A (fr) | Anticorps contre entpd2, polythérapies, et procédés d'utilisation des anticorps et des polythérapies | |
| WO2018089261A3 (fr) | Composés et méthodes de modulation de kinase de lymphocytes t inductible par l'interleukine 2 | |
| PH12016501538A1 (en) | Use of 3-isoxazolidinones compounds as selective herbicides | |
| WO2018042343A3 (fr) | Composés inhibant les protéases 3c et 3cl et leurs méthodes d'utilisation | |
| IL277072A (en) | Anti-claudin antibodies 18.2 | |
| MX2018010971A (es) | Compuestos y métodos para modular la tirosina cinasa de bruton. | |
| WO2017177222A8 (fr) | Système et procédé de recherche et de mise en correspondance de contenu sur des réseaux sociaux pertinent pour un individu | |
| WO2016172726A9 (fr) | Modulateurs de la liaison ror1-ror2 | |
| PH12017502067A1 (en) | Insecticidal arylpyrrolidines, method for synthesizing same, and use thereof as agents for controlling animal pests | |
| MA52492A (fr) | Composés inhibiteurs de rip1, procédés de préparation et d'utilisation associés | |
| BRPI0507794A (pt) | métodos de modular a atividade de il-23, reagentes relacionados | |
| EP3755635C0 (fr) | Cartons empilables, système, et leurs procédés d'utilisation | |
| WO2015143188A8 (fr) | 2-(2,4-difluorophényl)-1,1-difluoro-1-(pyridin-2-yl 5-substitué)-3-(1h-tétrazol-1-yl)propan-2-ols et procédés pour les préparer | |
| DK1708536T3 (da) | Fremgangsmåde til administration af radioresourcer samt Node B-apparat til implementering af samme | |
| TW200736195A (en) | Methods for preparing sulfonamide substituted alcohols and intermediates thereof | |
| WO2020061478A3 (fr) | Méthodes de purification d'anticorps hétérodimères multispécifiques | |
| IL282006B1 (en) | Treatment of bone tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide | |
| EP3774027A4 (fr) | Électro-catalyseurs, leur préparation,et leur utilisation pour la synthèse de l'ammoniac | |
| FR2908600B1 (fr) | Capsicum microencapsule, procede pour sa preparation, et utilisation | |
| FR3044660B1 (fr) | Enduit interieur en pate, procede d'application et dispositif de melange et de projection de l'enduit | |
| DK3752490T3 (da) | Herbicide 3-azaspiro[5.5]undecan-8,10-dionforbindelser | |
| EP3607476A4 (fr) | Réseau distribué pour la collecte, l'analyse et le partage sécurisés de données sur des plateformes | |
| MX2018013937A (es) | Cristales. | |
| WO2021055577A3 (fr) | Anticorps anti-klk7, anticorps anti-klk5, anticorps multispécifiques anti-klk5/klk7, et leurs procédés d'utilisation | |
| EP3551612A4 (fr) | Procédé de préparation de n-(4-(6,7-diméthoxyquinolin-4-yloxy) phényl)-n'-(4-fluorophényl)cyclopropane-1, 1-dicarboxamide, (2s)-hydroxybutanedioate et ses polymorphes |